Health News Releases

  • Today February 18
March 04, 2016 10:30
GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval
At the Houston Aortic Symposium today, W. L. Gore & Associates, Inc. (Gore) announced the Food and Drug Administration (FDA) approval of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE), making i
March 02, 2016 19:55
ReSound® Introduces the World’s Smartest Super Power Hearing Aid
Today, GN ReSound announced the global launch of ReSound ENZO2™, bringing the renowned benefits of ReSound LiNX2™ to people with severe to profound hearing loss in need of a Super Power solution. A
March 02, 2016 11:45
Alexion Employees Across the Globe Join Together to Support Rare Disease Day 2016
Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) joins the worldwide rare disease community in honoring the ninth annual international Rare Disease Day. Rare Disease Day takes place the last day of Februar
March 02, 2016 09:40
European Committee for Medicinal Products for Human Use recommends approval of Giotrif® (afatinib) for advanced squamous cell cancer of the lung
Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) (http://goo.gl/fbcEKu) issued a positive opinion (http://goo.
February 29, 2016 17:40
New survey gives voice to people living with a rare and devastating lung disease: “When I think of IPF I think of breathlessness”
An international survey of over 500 people living with idiopathic pulmonary fibrosis (IPF) in more than 20 countries worldwide reveals the real-life emotions faced by those with the devastating diseas
February 29, 2016 11:30
Mitsubishi Tanabe Pharma Corporation Signs Licensing Agreement with A. Menarini Asia-Pacific for Spedra (Avanafil) in 10 Countries in Asia-Pacific
Mitsubishi Tanabe Pharma Corporation (TSE: 4508), and Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd (“Menarini AP”) have entered into a licensing agreement to commercialize and promote SPE
February 26, 2016 17:40
Manipal Hospitals is the First in India to Adopt Masimo Patient SafetyNet™
Masimo (NASDAQ: MASI) announced today that Manipal Hospitals is the first hospital in India to install Masimo Patient SafetyNet™, a remote monitoring and clinician notification system. “With Patien
February 26, 2016 14:30
New analysis confirms OFEV® (nintedanib) slows disease progression in IPF and reduces risk of acute exacerbations
Pooled analysis from the TOMORROW and INPULSIS® trials, recently published in Respiratory Medicine, provides further evidence that OFEV® (nintedanib) significantly reduces the risk of acute exacerbati
February 24, 2016 16:20
Primex Pharmaceuticals: New Acquisition Brings an Innovative Oral Solution for Pediatric Anesthesiology to the Market
Swiss pharmaceutical company Primex Pharmaceuticals AG and French pharmaceutical laboratory Advicenne SA announced today a deal where Primex will acquire global rights for an advanced oral pharmaceuti
February 23, 2016 21:55
Quintiles Named to Fortune Magazine's 2016 List of “World’s Most Admired Companies”
Quintiles, the world’s largest biopharmaceutical services company, has been named to Fortune magazine’s “World’s Most Admired Companies” list for 2016, the second year in a row for this distinction.
February 23, 2016 01:00
InFo Instant Focus© - A Revolution in Natural Lens Surgery for Cataract
The company Swiss Advanced Vision (SAV-IOL SA - www.sav-iol.com) announced the launch of a product without competition in the medical field. The intraocular lens (IOL) InFo Instant Focus© indicated fo
February 19, 2016 14:10
Oral Ozanimod 72-Week Phase 2 Results From RADIANCE Trial in Relapsing Multiple Sclerosis Presented At ACTRIMS
Celgene Corporation (NASDAQ:CELG) today announced 72-week results from the RADIANCE phase 2 trial of ozanimod, an investigational selective S1P 1 and 5 receptor modulator, in patients with relapsing m
February 18, 2016 13:55
SAB Biotherapeutics Produces New Human Antibody Treatment for MERS-CoV
SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company, announced today it has produced a new human antibody therapeutic to treat the deadly Middle East respiratory syndrome
February 18, 2016 12:00
Australian Expert in Sports Science and Nutrition Joins Herbalife Nutrition Advisory Board
Global nutrition company, Herbalife announced today that Dr. Darren Burgess, an expert in sports science and nutrition, has become the first Australian appointed to its Nutrition Advisory Board (NAB).
February 17, 2016 11:50
GORE® EXCLUDER® Device Reaches Significant Milestone
W. L. Gore & Associates, Inc. (Gore) (www.goremedical.com) today announced that more than 250,000 patients have been treated* with the GORE® EXCLUDER® AAA Endoprosthesis. The GORE EXCLUDER Device has
February 16, 2016 22:00
Replicor to Present Pre-Clinical and Updated Clinical Data on REP 2139-Ca Based Combination Therapy in Chronic HBV and HBV / HDV Co-Infection at APASL 2016
Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B virus (HBV) and chronic HBV and hepatitis delta virus (HDV) co-infection, will present
February 15, 2016 11:15
CiteAb Names Cell Signaling Technology, “Antibody Company of the Year” and “Researchers’ Choice”
Cell Signaling Technology (CST), a leading provider of antibodies, kits and services, was honored with the 2016 CiteAb Award for “Researchers’ Choice” and for a second year in a row with the award for
February 12, 2016 13:05
Morinaga Milk's B. longum BB536 Probiotic May Prevent Intestinal Disorders Induced by Animal-Based Diet
Morinaga Milk Industry Co., Ltd. (www.morinagamilk.co.jp/english) (TOKYO:2264), a leading dairy product company in Japan, today unveiled new research showing that daily consumption of yogurt fortified
February 11, 2016 14:25
The European Society of Cardiology announces winners of innovative cardiovascular research grant programme
The European Society of Cardiology (ESC) has announced five winners of the competitive research programme ‘Grants for Medical Research Innovation’, exclusively supported by an independent grant from B
February 10, 2016 15:25
Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide
Ferring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major adverse cardiovascular events (MACEs) in patients with prostate
February 10, 2016 14:00
ASTRAZENECA’S COMBINATION OF DURVALUMAB WITH TREMELIMUMAB SHOWS CLINICAL ACTIVITY IN NON-SMALL CELL LUNG CANCER IRRESPECTIVE OF PD-L1 STATUS
AstraZeneca and MedImmune, its global biologics research and development arm, today announced publication in The Lancet Oncology of a Phase Ib study (study 006), showing antitumour activity of combina
February 10, 2016 12:00
Quintiles Wins 2016 Leadership Excellence Award
Quintiles, the world’s largest biopharmaceutical services company, has been awarded the HR.com 2016 Leadership Excellence Award for Innovation in Deployment of Leadership Programs. This Smart News
February 05, 2016 14:00
In New Clinical Study Masimo’s Oxygen Reserve Index Helps Clinicians Detect Impending Desaturation in Pediatric Patients
Masimo (www.masimo.com) (NASDAQ: MASI) announced today that in a new clinical study, Masimo’s Oxygen Reserve Index (ORI™), the first noninvasive and continuous parameter to provide insight into patien
February 04, 2016 18:35
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a onc
February 04, 2016 17:10
NAMSA Announces Divestiture of its Sterility Assurance Products Division
North American Science Associates, Inc. (NAMSA), the world’s leading medical research organization (MRO®) today announced a definitive agreement to divest its Sterility Assurance Products Division of
25 per page50 per page75 per page100 per page